Brain histamine H1 receptor occupancy of newly-marketed non-sedating antihistamines: PET measurement in normal volunteers

Trial Profile

Brain histamine H1 receptor occupancy of newly-marketed non-sedating antihistamines: PET measurement in normal volunteers

Completed
Phase of Trial: Phase IV

Latest Information Update: 22 Apr 2015

At a glance

  • Drugs Fexofenadine (Primary) ; Levocetirizine (Primary)
  • Indications Allergic rhinitis; Dermatitis; Perennial allergic rhinitis; Pruritus; Seasonal allergic rhinitis; Urticaria
  • Focus Pharmacodynamics
  • Most Recent Events

    • 20 Apr 2015 Status changed from recruiting to completed, according to University Hospital Medical Information Network - Japan
    • 06 Mar 2012 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top